These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 15448669
1. Targeting PML/RARalpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells. Kabuli M, Yin JA, Tobal K. Hematol J; 2004; 5(5):426-33. PubMed ID: 15448669 [Abstract] [Full Text] [Related]
2. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [Abstract] [Full Text] [Related]
3. Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells. Nason-Burchenal K, Allopenna J, Bègue A, Stéhelin D, Dmitrovsky E, Martin P. Blood; 1998 Sep 01; 92(5):1758-67. PubMed ID: 9716606 [Abstract] [Full Text] [Related]
5. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. Testa U, Grignani F, Samoggia P, Zanetti C, Riccioni R, Lo Coco F, Diverio D, Felli N, Passerini CG, Grell M, Pelicci PG, Peschle C. J Clin Invest; 1998 May 15; 101(10):2278-89. PubMed ID: 9593784 [Abstract] [Full Text] [Related]
6. [Study on the role of PML-RARalpha and RARalpha fusion proteins in NB4 cell apoptosis induced by arsenic trisulfide]. Hao HY, Teng ZP, Lu DP. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr 15; 10(2):108-11. PubMed ID: 12513809 [Abstract] [Full Text] [Related]
7. Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis. Ward SV, Sternsdorf T, Woods NB. Hum Gene Ther; 2011 Dec 15; 22(12):1593-8. PubMed ID: 21846246 [Abstract] [Full Text] [Related]
13. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells. Jing Y, Xia L, Lu M, Waxman S. Oncogene; 2003 Jun 26; 22(26):4083-91. PubMed ID: 12821942 [Abstract] [Full Text] [Related]
14. UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation. Shah SJ, Blumen S, Pitha-Rowe I, Kitareewan S, Freemantle SJ, Feng Q, Dmitrovsky E. Mol Cancer Ther; 2008 Apr 26; 7(4):905-14. PubMed ID: 18413804 [Abstract] [Full Text] [Related]
17. Alteration in the cellular response to retinoic acid of a human acute promyelocytic leukemia cell line, UF-1, carrying a patient-derived mutant PML-RARalpha chimeric gene. Sato A, Imaizumi M, Hoshi Y, Rikiishi T, Fujii K, Kizaki M, Kagechika H, Kakizuka A, Hayashi Y, Iinuma K. Leuk Res; 2004 Sep 26; 28(9):959-67. PubMed ID: 15234573 [Abstract] [Full Text] [Related]
18. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM, He LZ, Warrell RP, Wang ZG, Pandolfi PP. Proc Natl Acad Sci U S A; 2000 Aug 29; 97(18):10173-8. PubMed ID: 10954752 [Abstract] [Full Text] [Related]